Navigation Links
EastMed Inc. receives FDA clearance to market uresta(TM) in the U.S.
Date:11/25/2008

NORWELL, MA, Nov. 25 /PRNewswire/ - EastMed Inc., the medical manufacturing company that caters specifically to women's health and wellness, has received FDA clearance to market its flagship product, uresta(TM) Continence Care, in the U.S.

"We are delighted to get the official word from the FDA," said James Lodigiani, CEO and President of EastMed Inc. "Uresta (TM) Continence Care offers an innovative and cost-effective option for the many women who suffer from Stress Urinary Incontinence (SUI)."

Uresta(TM) Continence Care is designed to stop bladder leakage and empower women to manage their SUI with a conservative alternative to traditional products and surgery.

It is estimated that one in three women worldwide have incontinence and more than half of those women have SUI.

"SUI is a widespread, life altering condition and requires a solution that women can easily and comfortably manage," says Dr. Scott Farrell, Founder and VP Medical, EastMed. "Uresta(TM) Continence Care restores self-confidence and allows women to improve their quality of life."

Uresta(TM) Continence Care will be available by prescription in the United States.

EastMed Inc. is dedicated to inventing and bringing to market medical innovations for women's health and wellness. The company was recently awarded the 2008 Medical Design Excellence Award (MDEA) in recognition of its innovative design for women who suffer with SUI. EastMed has also received ISO world class quality certification, standards of quality recognized and respected throughout the world.


'/>"/>
SOURCE Eastmed Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. SuperGen Receives Clearance to Begin Clinical Trials With SGI-1776, a PIM Inhibitor
2. Serica Technologies Receives ISO Certification, Meets International Standards for Medical Device Manufacturing
3. Bavarian Nordic Receives USD 25 Million Milestone Payment After Submission of Important IMVAMUNE(R) Data to The U.S. Health Authorities
4. Cellectricon Receives Milestone Order for Cellaxess(R)HT, the Worlds First High Throughput RNAi Screening System
5. China Medical Technologies Receives SFDA Approval for Breast Cancer HER-2 FISH Probe
6. West Michigans Newest Medical Device Company Receives Support from the West Michigan Science & Technology Initiative and EDF Ventures
7. ProtoKinetix Receives Independent Confirmation of AAGP Anti-Inflammatory Action
8. Valor Medical Closes $1.4 Million Convertible Debt and Receives ISO 13485 Certification
9. Aposense Receives Frost & Sullivan Technology Innovation of the Year Award
10. Solos Endoscopy, Inc. Receives Purchase Order from Connecticut Hospital
11. Caraco Pharmaceutical Laboratories, Ltd. Receives FDA Warning Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... -- Liquid Biotech USA , Inc. ... Research Agreement with The University of Pennsylvania ("PENN") ... patients.  The funding will be used to assess ... outcomes in cancer patients undergoing a variety of ... to support the design of a therapeutic, decision-making ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers ... 5000 and the 6000i models are higher end machines that use the more unconventional ... spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci has ...
(Date:6/23/2016)...   Boston Biomedical , an industry leader ... target cancer stemness pathways, announced that its lead ... Designation from the U.S. Food and Drug Administration ... gastroesophageal junction (GEJ) cancer. Napabucasin is an orally ... stemness pathways by targeting STAT3, and is currently ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is ... has received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval ... Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods ...
Breaking Biology Technology:
(Date:4/15/2016)... -- A new partnership announced today will help life ... a fraction of the time it takes today, ... insurance policies to consumers without requiring inconvenient and ... rapid testing (A1C, Cotinine and HIV) and higi,s ... pulse, BMI, and activity data) available at local ...
(Date:4/13/2016)... 13, 2016  IMPOWER physicians supporting Medicaid patients in ... new clinical standard in telehealth thanks to a new ... higi platform, IMPOWER patients can routinely track key health ... mass index, and, when they opt in, share them ... to a local retail location at no cost. By ...
(Date:3/29/2016)... Florida , March 29, 2016 ... the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased ... in ink used in a variety of writing instruments, ... Buyers of originally created collectibles from athletes on LegacyXChange ... forensic analysis of the DNA. Bill ...
Breaking Biology News(10 mins):